Skip to content
Dx

HCPCS Level II · Miscellaneous services (temporary codes)

Q2057Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose

✓ Active

Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.

About Q2057

Q2057 is an HCPCS Level II code in the Q series (miscellaneous services (temporary codes)), describing afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose.

It was added to HCPCS effective 04/01/2025, and its current record took effect 01/01/2026.

Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.

Details

Short description
Afamitresgene autoleucel
Date added
04/01/2025
Action effective
01/01/2026
BETOS
O1D

Related Q20xx codes

Common questions about Q2057

Is HCPCS Q2057 still valid?

Yes. Q2057 is active in the CMS October 2026 HCPCS file.

Does Medicare cover Q2057?

Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.